Heppe Medical Chitosan

What Heppe Medical Chitosan does

Heppe Medical Chitosan GmbH (HMC+) is a privately held German specialty biopolymer manufacturer based in Halle (Saale), Germany, that develops, produces, and sells chitin, chitosan, and chitosan derivatives for the global medical technology and pharmaceutical industries. The company's core offering is a portfolio of over 100 different chitin, chitosan, and derivative products — including Chitosan HCl, Chitosan Glutamate, Carboxymethyl Chitosan, Chitosan Lactate, and Chitosan Acetate — manufactured at a single GMP-compliant facility in Germany under a TÜV Rheinland quality management certification held continuously since 2011. In 2023 the company introduced what it describes as the world's first chitosan molecular weight standards, a reference-material product that allows researchers to calibrate molecular weight using chitosan rather than pullulan or PEG/PEO references.

HMC+ commercializes its products through three tiered shop brands — Chitoscience for general research, Chitoceuticals for pharmaceutical R&D with extended analytical documentation, and Chitoceuticals GMP-compliant chitosan for clinical and regulated applications — sold via an owned e-commerce storefront and direct B2B sales. Beyond product sales, the company generates revenue from custom manufacturing (Lohnproduktion), contract research and analytical services, consulting (including a 'Rent a Chitosanist' offering), and educational workshops, primarily targeting medical device manufacturers, pharmaceutical companies and CDMOs, university researchers, and industrial R&D departments. The company is led by founder-CEO Katja Richter (Dipl.-Biotechnologin), maintains active participation in EUCHIS and trade events such as CPHI and MEDICA, and is integrated into the Weinberg Campus / DE:Hub Halle startup ecosystem. The firm has received early-stage venture funding from HTGF and KI Kapital (2008 seed, 2010 Series 2) and operates without disclosed institutional backing beyond that point.

Name

Heppe Medical Chitosan

Legal name

Heppe Medical Chitosan GmbH

Website

https://gmp-chitosan.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Heppe Medical Chitosan GmbH is a German specialty biopolymer manufacturer that develops and produces GMP-compliant chitin, chitosan, and over 100 chitosan derivatives for global medical technology, pharmaceutical, and research customers from its facility in Halle (Saale).

Ownership category

akta.pro rank

Product category

Pharmaceutical Biopolymers

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)

Keywords

• Pharmaceutical biopolymers
• GMP chitosan manufacturing
• Chitosan derivatives
• Medical grade chitin
• Custom biopolymer production

Headquarters

HQ city

Halle An Der Saale

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Chitosan product sales: Direct sales of chitin, chitosan, and derivatives through own e-commerce shop (Chitoscience for general research, Chitoceuticals for pharmaceutical R&D, GMP-compliant products). Products sold in various quantities from small research amounts to larger industrial volumes.
2. Custom manufacturing: Contract/custom manufacturing services (Lohnproduktion) for specialized chitosan products tailored to specific customer requirements in MedTech and Pharma.
3. Contract research: Research services including analytical services, custom analyses, and application consulting for university and industrial research customers.
4. Workshops and training: Educational workshops on chitosan applications, properties, and use cases for customers and researchers.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Heppe Medical Chitosan GmbH (HMC+) develops, produces, and distributes biopolymers — chitin, chitosan, and over 100 chitosan derivatives — manufactured under GMP-compliant conditions in Halle (Saale), Germany, for the global medical technology and pharmaceutical industry. The company operates specialized shop brands (Chitoscience for general research, Chitoceuticals for pharmaceutical R&D, GMP-compliant Chitoceuticals) and provides custom manufacturing, contract research, analytical services, and consulting.

Product overview

Heppe Medical Chitosan GmbH (HMC+) operates as a biopolymer manufacturer offering a comprehensive portfolio centered on chitin, chitosan, and their derivatives for the scientific and medical sectors. The product range spans over 100 different chitosan and chitosan derivative varieties produced in Germany under GMP conditions. Core offerings include raw materials (Chitin, Chitosan), five derivative forms (Chitosan HCl, Chitosan Glutamate, Carboxymethyl Chitosan, Chitosan Lactate, Chitosan Acetate), and standardized products. The company serves distinct market segments through specialized shop brands: Chitoscience for general research with standard analyses, Chitoceuticals for pharmaceutical R&D with extended analytical packages, and GMP-compliant Chitoceuticals for clinical and regulatory applications. Supporting the product portfolio are custom manufacturing, contract research, consulting services, workshops, and analytical services. The company also pioneered world-first chitosan molecular weight standards for reliable analytical comparison.

Differentiator

Problem solved

Functional benefit

Brands

• Chitoscience: Chitin, chitosan and derivatives for general research needs, including standard analyses
• Chitoceuticals
• Chitoceuticals GMP compliant Chitosan

Products and services

• Chitin Raw biopolymer material derived from chitin, offered as part of HMC+'s core product portfolio for scientific and medical applications, available as raw material for chitosan production and direct end-use.
• Chitosan Primary biopolymer product developed, produced, and sold by HMC+ for research and medical sector applications, available in over 100 different varieties with varying degrees of deacetylation and molecular weights.
• Chitosan HCl Water-soluble chitosan salt derivative suitable for pharmaceutical and biomedical applications requiring enhanced solubility.
• Chitosan Glutamate Chitosan salt derivative with glutamate counterion, designed for applications requiring specific solubility and ionic properties.
• Carboxymethyl Chitosan Modified chitosan derivative with carboxymethyl substituents, offering improved water solubility and functional properties for specialized applications.
• Chitosan Lactate Chitosan salt derivative with lactate counterion, developed for applications requiring specific chemical and biological properties.
• Chitosan Acetate Acetate salt form of chitosan designed for pharmaceutical and research applications requiring specific ionic characteristics.
• Chitosan Standard Standardized chitosan products with consistent quality specifications for research and industrial applications.
• Chitoscience (shop brand) Product line offering chitin, chitosan and derivatives for general research needs, including standard analyses. Targets academic and general research institutions.
• Chitoceuticals (shop brand) Purified chitin, chitosan and derivatives for pharmaceutical research and development, featuring an extended analytical package for enhanced quality documentation.
• Chitoceuticals GMP compliant Chitosan (shop brand) GMP-compliant chitosan products specifically designed for pharmaceutical development and clinical trial applications requiring regulatory compliance.
• Chitosan Molecular Weight Standards World-first chitosan standards for molecular weight analysis, enabling researchers to use reliable chitosans for accurate molecular weight determination instead of comparing with pullulan or PEG/PEO standards.
• Custom Manufacturing (Lohnproduktion) Custom manufacturing services allowing customers to have chitosan products produced to their specific requirements and formulations for medical technology and pharmaceutical applications.
• Contract Research (Auftragsforschung) Collaborative research services supporting customers in developing and optimizing chitosan applications for specific industrial or medical uses.
• Consulting (Beratung) Expert consulting services for customers seeking guidance on chitosan applications, specifications, and implementation in pharmaceutical or medical products.
• Workshops Training and educational workshops on chitosan science, applications, and best practices for researchers and industry professionals.
• Service/Analyses Contract analytical services and additional analyses for customers requiring specialized testing and quality documentation beyond standard product specifications.
• Rent a Chitosanist Specialized consulting service providing expert chitosan knowledge and support for specific project needs and technical challenges.

Quantifiable outcome

• TÜV certified quality management since 2011
• +1 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered minor and core.

• PerioTrap PharmaceuticalsminorStrategic or Co-development Partner · 26 June 2025HMC+ joined forces with PerioTrap Pharmaceuticals to showcase startup-driven growth and translation in the Halle life science ecosystem at NextRise 2025 in Seoul, South Korea.
• DE:Hub HallecoreStrategic or Co-development Partner · 26 June 2025DE:Hub Halle is a unique platform for startups working on digital and nature-based innovations that benefit both human health and the environment. HMC represents Halle and the DE:Hub Initiative at international events.
• EUCHIS (European Chitin Society)coreStrategic or Co-development PartnerEUCHIS is a non-profit organization encouraging basic and applied scientific studies of all aspects of chitin and chitosan. Katja Richter, CEO of Heppe Medical Chitosan, serves on the scientific committee. HMC actively participates in EUCHIS conferences.
• Weinberg CampuscoreStrategic or Co-development PartnerLocated within the Weinberg Campus ecosystem, HMC benefits from the integrated ecosystem between Weinberg Campus and Blankenburg for startup-driven innovation in life sciences.
• IHK Halle/SaaleminorOthersChamber of commerce membership for business networking and industry representation in the Halle/Saale region.

Scale indicators3 records

Recent moves3 records

Expansion highlights4 records

Direct peers

• Primex ehf: Direct peer: Icelandic manufacturer of chitosan and chitin derivatives from North Atlantic shrimp shells, serving cosmetics, nutraceuticals, and biomedical applications. Most comparable competitor to HMC by product, customer segments, and GMP-grade positioning.
• Qingdao Yunzhou Bioengineering Co., Ltd. Direct peer: one of the largest Chinese producers of chitin, chitosan, and chitosan derivatives, serving food, cosmetic, agricultural, and pharmaceutical applications. Comparable on core chemistry and product family; competes primarily on scale and cost.
• Golden-Shell Biochemical Co., Ltd. Direct peer: Chinese chitosan and chitin derivative manufacturer with broad product portfolio for food, cosmetic, water treatment, and pharma use. Overlaps with HMC on the chemical/derivative side and competes on volume.

Broad incumbents

• Merck KGaA (Sigma-Aldrich): Broad incumbent: offers research-grade chitosan and chitosan oligosaccharides as part of a much larger life-science chemicals catalogue. Competes for research customers but does not specialize in GMP-grade chitosan supply.
• TCI Chemicals: Broad incumbent: specialty chemical supplier offering chitosan and selected derivatives for research use. Not a specialist in chitosan or GMP manufacturing, but competes for the same research-shop customers.
• Biosynth Carbosynth: Broad incumbent: specialty chemicals and carbohydrates supplier with a research-grade chitosan offering. Comparable on distribution model and academic/pharma customer base; not a chitosan specialist.

Emerging players

• Glentham Life Sciences: Emerging player: UK-based specialty chemical supplier offering chitin and chitosan research chemicals. Comparable as a smaller European catalogue competitor focused on the academic and early-stage research market segment HMC's Chitoscience tier addresses.
• Polysciences, Inc. Emerging player: US manufacturer of specialty polymers and chemicals including chitosan and chitosan derivatives for biomedical, cosmetic, and research use. Overlaps with HMC on biomedical-grade chitosan supply and CDMO-adjacent custom polymer manufacturing.
• Chitogenx (formerly NovaBay/Altus): Emerging player: chitosan-based medical device and pharmaceutical development company. Not a direct materials supplier like HMC, but operates downstream in chitosan-based drug delivery and wound care — useful as a downstream demand-side comparable for HMC's GMP supply opportunity.

Others

• bio-techne (R&D Systems / Tocris): Others: life-science reagents supplier serving pharma R&D and academic research with a broad catalogue that includes select chitosan products. Comparable on customer base (pharma R&D, academic research) and on the e-commerce/direct-distribution model HMC uses for Chitoscience.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/heppe-medical-chitosan-gmbh

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Heppe Medical Chitosan